DHSM - DHS Holding, Co. Receives License to Operate

New Post Public Reply Private Reply Replies (0) Message Board
SevenTenEleven

DHSM - DHS Holding, Co. Receives License to Operate Casino in Belize

NASHVILLE, TN--(Marketwire - Oct 1, 2012) - DHS Holding, Co. (PINKSHEETS:  DHSM ), announces today that the Belize Gaming Control Board has awarded DHS Belize, LTD a license to operate a land-based casino, contingent upon site plans, environmental clearance and inspection. With the license granted, DHS Holding, Co. can now begin its development of the long-anticipated Cenote Falls Hotel & Casino.

Company President Charles Barrett stated, "This is great news. These contingencies are the norm for obtaining a gaming license and should in no way hinder our efforts to move forward."

All current DHS Holding, Co. information can be found on OTCMarkets.com and on DHSHolding.com.

About the company
The primary focus of DHS Holding, Co. is directed to pursue mergers and acquisitions of companies with potential for growth and success. DHS is aggressively moving to develop and expand on both domestic and international opportunities that include building a hotel and casino in Belize and launching an online casino through DHS Belize, LTD, a wholly-owned subsidiary of DHS Holding, Co.

Source Information
www.dhsholding.com
www.otcmarkets.com/stock/dhsm/quote

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes," "expects," "anticipates," "intends," "estimates," "plans," "projects," "should," or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 5

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 8

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

Storelocal Storage Helps Hurricane Victims with Free Storage

Updated Category News Views 45

Storelocal Storage's Generous Offer to Hurricane Victims Storelocal Storage has initiated a compassionate program supporting victims of Hurricane Helene by offering two months of complimentary self-storage at its facilities. This initiative focuses on aiding individuals and families who are navigating the challenging process of rebuilding their lives after the recent...

Continue Reading
Investigation into DocGo Inc. Focuses on False Statements

Updated Category News Views 261

Investigation into DocGo Inc.'s Possible Misconduct Schubert Jonckheer & Kolbe LLP is currently conducting an investigation regarding potential legal claims against DocGo Inc. (NASDAQ: DCGO) in light of allegations involving false statements. These claims particularly concern the educational background of DocGo's former CEO and assertions made about the company's market...

Continue Reading
Amplify Energy's Strategic Acquisition of Juniper Capital Assets

Updated Category News Views 132

Amplify Energy’s Strategic Move to Acquire Juniper Capital's Assets Today, Amplify Energy Corp. (NYSE: AMPY) has shared an exciting update regarding its decision to acquire the upstream Rocky Mountain portfolio of Juniper Capital. This acquisition is not just a merger; it's a vital step in Amplify's mission to bolster its portfolio and future growth prospects. Unpacking...

Continue Reading
Discover the Inspiring Journey of ''Sunshine in My Heart''

Updated Category News Views 112

Introducing ''Sunshine in My Heart'' Xulon Press proudly presents the first volume of My Sun & Shade book series, an empowering narrative aimed at women, chronicling profound moments of personal growth and spiritual enlightenment. A Journey of Faith and Resilience Written by Angela M. Viola, this memoir invites readers into a deeply personal story that unfolds the themes...

Continue Reading
Civitas Resources Adjustments: KeyBanc's Insights and Outlook

Updated Category News Views 57

KeyBanc Adjusts Price Target for Civitas Resources KeyBanc Capital Markets has recently updated its price target for Civitas Resources (NYSE:CIVI), a company known for its oil and gas production activities, reducing it from $94.00 to $84.00. This revision reflects current investor concerns regarding the company's projected oil production for 2025, mainly due to a...

Continue Reading